Objective. To explore the patients' attitudes towards the long-acting injectable antipsychotics. Material and methods. Authors surveyed 164 psychotic outpatients. Results. Psychiatrists suggested long-acting injectable antipsychotics to 59.7% of the patients. Among these patients, 64.3% agreed with and 35.5% rejected this treatment. The fear of side-effects (57.1%) and the need of regular visits to psychiatrists (48.6%) were the main reasons of the rejection. The advantages of long-acting injectable antipsychotics, as viewed by the patients, and some obstacles to their use were determined. Conclusion. Psychoeducational and psychoterapeutical programs for patients and psychiatrists are needed.